Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.

類似資料

• Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting
  著者:: Abernethy, Amy P., 等
  出版事項: (2017)
• Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
  著者:: Cai, Weijing, 等
  出版事項: (2015)
• Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations
  著者:: Lou, Na-Na, 等
  出版事項: (2016)
• Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
  著者:: Marino, Federica Zito, 等
  出版事項: (2015)
• Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target
  著者:: Galetta, Domenico, 等
  出版事項: (2016)